Prevention of experimental allergic encephalitis in guinea-pigs with spinal cord protein: optimum pretreatment schedules and appraisal of plausible mechanisms

scientific article

Prevention of experimental allergic encephalitis in guinea-pigs with spinal cord protein: optimum pretreatment schedules and appraisal of plausible mechanisms is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID75839

P2093author name stringArmstrong H
Tan O
Macpherson CF
P2860cites workThe use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" typeQ36334374
Further characterization of the anti-encephalitogenic protein (SCP): isolation from bovine spinal cord and spinal rootsQ39360896
Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.Q39940689
Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelinQ44956993
Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanismQ46142436
Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitisQ46172882
Large scale preparation of myelin basic protein from central nervous tissue of several mammalian speciesQ46193929
ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.Q46297287
Antigen-induced inhibition of experimental allergic encephalomyelitis. I. Inhibition in guinea pigs injected with non-encephalitogenic modified myelin basic proteinQ46794339
Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic proteinQ46956231
Studies on brain antigens. VI. Prevention of experimental allergic encephalomyelitis by a water-soluble spinal cord protein, 1 -SCP.Q48004129
Studies on brain antigens. V. Purification and partial characterization of an anti-encephalitogenic spinal cord protein (SCP).Q48719268
Studies of cyclophosphamide suppression of experimental allergic encephalomyelitis in Wistar ratsQ48974601
Clinico-pathologic correlations in experimental allergic encephalomyelitis. II. Development of an index for quantitative assay of encephalitogenic activity of antigensQ78702930
Suppression of Experimental Allergic Encephalomyelitis by StressQ78983474
P433issue2
P921main subjectencephalitisQ199615
P304page(s)161-166
P577publication date1977-08-01
P1433published inImmunologyQ15754984
P1476titlePrevention of experimental allergic encephalitis in guinea-pigs with spinal cord protein: optimum pretreatment schedules and appraisal of plausible mechanisms
P478volume33

Reverse relations

cites work (P2860)
Q72134892Immunohistological localization of the anti-encephalitogenic bovine spinal cord protein (BSCP) in axons
Q72751328One-way humoral immune cross-reactivity between bovine spinal cord protein and bovine myelin basic protein
Q72620535Suppression and treatment of experimental allergic encephalitis in guinea-pigs with the bovine spinal cord protein (BSCP)

Search more.